VaramirStart free · no cardSign in
KRYS as of Nov 1 · 17:21 ET
KRYSNasdaqBiological Products, (No Diagnostic Substances)

Krystal Biotech, Inc. · Brief

Next report

1 day

Nov 2 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±9.6%
avg realized
±6.7%
Aug 5 '24±13.1%▼−5.85%×0.45
Nov 4 '24±11.9%▼−3.14%×0.26
May 6 '25±9.3%▼−14.06%×1.51
Aug 4 '25±9.3%▼−14.04%×1.51
Nov 3 '25±11.1%▲+0.17%×0.02
Jan 12 '26±3.8%▲+4.10%×1.07
Q1 FY26±8.1%▲+4.12%×0.51
Q2 FY26±10.1%▼−8.37%×0.83
quarterimplied−15%0+15%realized×
Q2 FY26±10.1%▼−8.37%×0.83
Q1 FY26±8.1%▲+4.12%×0.51
Jan '26±3.8%▲+4.10%×1.07
Nov '25±11.1%▲+0.17%×0.02
Aug '25±9.3%▼−14.04%×1.51
May '25±9.3%▼−14.06%×1.51
2 older reports
Nov '24±11.9%▼−3.14%×0.26
Aug '24±13.1%▼−5.85%×0.45
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · est.

Bull2

423managers reporting a position in the latest quarterly filings13F · Jun 30 '26
25managers whose positions together make up four fifths of reported value13F · Jun 30 '26

Bear2 of 3

5tracked funds holding KRYSN-PORT · Aug 31 '26
1.10%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

KRYS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 19impliedImplied move: ±9.4% into Nov 2 earnings (Oct 19 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.